Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women
Open Access
- 23 December 2017
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 142 (9), 1952-1958
- https://doi.org/10.1002/ijc.31212
Abstract
Objective: To evaluate the Turkey's nationwide HPV DNA screening program on the basis of first 1 million screened women. Methods: Women over age 30 were invited for population based screening via HPV DNA and conventional cytology. Samples were collected by family physicians and the evaluations and reports had been performed in the National Central HPV laboratories. Results: The acceptance rate for HPV based cervical cancer screening after first invitation was nearly 36.5%. Since HPV DNA tests have been implemented, cervical cancer screening rates have shown 4-5-fold increase in primary level. Through the evaluation of all, HPV positivity was seen in 3,5%. The commonest HPV genotypes were 16, followed by 51, 31, 52 and 18. Among the 37.515 HPV positive cases, cytological abnormality rate was 19,1%. Among HPV positive cases, 16.962 cases had HPV 16 or 18 or other oncogenic HPV types with abnormal cytology (>ASC-US). These patients were referred to colposcopy. The colposcopy referral rate was 1.6%. Among these, final clinico-pathological data of 3.499 patients were normal in 1.985 patients, CIN1 in 708, CIN2 in 285, CIN3 in 436 and cancer in 85 patients and only pap-smear program could miss 45.9% of ≥CIN3 cases Conclusion: The results of 1 million women including the evaluation of 13 HPV genotypes with respect to prevalence, geographic distribution and abnormal cytology results shows that HPV DNA can be used in primary level settings in order to have a high coverage rated screening program and is very effective compared to conventional pap-smear.Keywords
This publication has 20 references indexed in Scilit:
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Reassurance Against Future Risk of Precancer and Cancer Conferred by a Negative Human Papillomavirus TestJNCI Journal of the National Cancer Institute, 2014
- Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trialsThe Lancet, 2013
- Interlaboratory variation in the performance of liquid-based cytology: Insights from the ATHENA trialInternational Journal of Cancer, 2013
- Cervical Cancer Screening in Turkey: A Community-based Experience After 60 Years of Pap Smear UsageAsian Pacific Journal of Cancer Prevention, 2012
- Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical CancerVaccine, 2012
- Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological FindingsThe Journal of Infectious Diseases, 2010
- Pap smear screening in the primary health care setting: A study from TurkeyNorth American Journal of Medical Sciences, 2010
- HPV Screening for Cervical Cancer in Rural IndiaThe New England Journal of Medicine, 2009
- Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: Design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST)International Journal of Cancer, 2006